PPARGC1A and metabolic dysfunction-associated steatotic liver disease: Hyper‐ or hypomethylation of specific genes, like PPARG coactivator 1 Alpha (PPARGC1‐A), affects fatty acid β‐oxidation and correlates with insulin resistance in MASLD patients.76